A chikungunya virus-like particle vaccine reduces chikungunya disease in cynomolgus macaques and protection is mediated by antibody transferred from vaccinated humans. [PDF]
Coffey LL +27 more
europepmc +1 more source
Clinical Outcomes of AO/OTA Type C Distal Radius Fractures Treated With Volar Locking Plate Versus Fragment-Specific Plating. [PDF]
Zeiman M +10 more
europepmc +1 more source
Advances in African swine fever vaccine development: challenges and prospects. [PDF]
Utomo DIS, Dharmayanti NI, Putra MY.
europepmc +1 more source
Dual induction of tissue-resident T and B cell immunity for broad influenza protection with a nanofiber-VLP vaccine. [PDF]
Wang X +15 more
europepmc +1 more source
Exceeding expectations: factors contributing to the potency of human papillomavirus vaccines. [PDF]
Schiller JT +5 more
europepmc +1 more source
Evaluating the impact of attachment designs on canine derotation in clear aligner therapy: a finite element analysis. [PDF]
Kulkarni P, Batra P, Vaiid N.
europepmc +1 more source
Bivalent virus-like particles expressing SPECT1 and CSP trigger pre-erythrocytic malaria immunity and protect against transgenic <i>Plasmodium falciparum</i> sporozoite challenge in mice. [PDF]
Turan G +7 more
europepmc +1 more source
Immunogenicity Analysis of PCV3 Capsid Highly Expressed Using Baculovirus. [PDF]
Zhang B, Chao L, Cai Y, Li Y.
europepmc +1 more source
4.4 Generate VLPs expressing Pfs25 alone, Pfs48/45 alone and bivalent VLPs
Generate VLPs expressing Pfs25 alone, Pfs48/45 alone and bivalent ...
openaire +1 more source

